By Moncrief                                           S.R. No. 1231
         77R17823 KLA-D                           
                                 R E S O L U T I O N
 1-1           BE IT RESOLVED by the Senate of the State of Texas, 77th
 1-2     Legislature, Regular Session, 2001, That Senate Rule 12.03 be
 1-3     suspended in part as provided by Senate Rule 12.08 to enable the
 1-4     conference committee appointed to resolve the differences on House
 1-5     Bill No. 1094, relating to the creation of a state prescription
 1-6     drug program for certain Medicare beneficiaries, to consider and
 1-7     take action on the following matter:
 1-8           Senate Rule 12.03(4) is suspended to permit the committee to
 1-9     add Subsection (c) to proposed Section 531.302, Government Code, to
1-10     read as follows:
1-11           (c)  In adopting rules for the state prescription drug
1-12     program, the commission shall consult with an advisory panel
1-13     composed of an equal number of physicians, pharmacists, and
1-14     pharmacologists appointed by the commissioner.
1-15           Explanation:  This change is necessary to require the Health
1-16     and Human Services Commission to consult with an advisory panel in
1-17     adopting rules for the state prescription drug program.